User:Mr. Ibrahem/Rocuronium

Rocuronium, sold under a number of brands, is a medication used to paralyze muscles for endotracheal intubation, including rapid sequence induction (RSI). It may also be used to relax muscles during surgery and when people are on a ventilator. It is given by injection into a vein. A single dose begins working after about 45 to 120 seconds and lasts for 25 to 90 minutes.

Common side effects include low blood pressure and high blood pressure. Other serious side effects may include anaphylaxis and prolonged muscle weakness. While not well studied in pregnancy, no harms have been found. Breastfeeding shortly following use is likely okay. Rocuronium is a neuromuscular blocker of the non-depolarizing type.

Rocuronium was approved for medical use in the United States in 1994. It is avaliable as a generic medication. In the United States it costs about 40 USD for 500 mg as of 2020. In the United Kingdom this amount costs the NHS about 25 pounds. Rocuronium is stable at room temperature for about 12 weeks.